Goeree R - Search Results

1

Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes.

Goeree R, Villeneuve J, Goeree J, Penrod JR, Orsini L, Tahami Monfared AA. Goeree R, et al. Among authors: goeree j. J Med Econ. 2016 Jun;19(6):630-44. doi: 10.3111/13696998.2016.1151432. Epub 2016 Mar 1. J Med Econ. 2016. PMID: 26850122 Free article.

2

Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.

Goeree R, Goeree J. Goeree R, et al. Among authors: goeree j. J Med Econ. 2016;19(3):277-91. doi: 10.3111/13696998.2015.1116992. Epub 2015 Nov 30. J Med Econ. 2016. PMID: 26535790 Free article.

3

Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada.

Moshyk A, Martel MJ, Tahami Monfared AA, Goeree R. Moshyk A, et al. Among authors: goeree r. J Med Econ. 2016;19(2):181-92. doi: 10.3111/13696998.2015.1106546. Epub 2015 Nov 11. J Med Econ. 2016. PMID: 26453248 Free article.

4

Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective.

Goeree R, Chiva-Razavi S, Gunda P, Jain M, Jugl SM. Goeree R, et al. J Med Econ. 2019 Jan;22(1):45-52. doi: 10.1080/13696998.2018.1539400. Epub 2018 Nov 13. J Med Econ. 2019. PMID: 30346844 Free article.

5

Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective.

Goeree R, Chiva-Razavi S, Gunda P, Graham CN, Miles L, Nikoglou E, Jugl SM, Gladman DD. Goeree R, et al. J Med Econ. 2018 Feb;21(2):163-173. doi: 10.1080/13696998.2017.1384737. Epub 2017 Oct 19. J Med Econ. 2018. PMID: 28945143 Free article.

6

Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada.

Patel V, Ahmed I, Podbielski D, Falvey H, Murray J, Goeree R. Patel V, et al. Among authors: goeree r. J Med Econ. 2019 Apr;22(4):390-401. doi: 10.1080/13696998.2019.1572013. Epub 2019 Feb 4. J Med Econ. 2019. PMID: 30663456 Free article.

7

Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada.

Chau D, Becker DL, Coombes ME, Ioannidis G, Adachi JD, Goeree R. Chau D, et al. Among authors: goeree r. J Med Econ. 2012;15 Suppl 1:3-14. doi: 10.3111/13696998.2012.737393. Epub 2012 Oct 16. J Med Econ. 2012. PMID: 23035625 Free article.

8

The economic burden of schizophrenia in Canada in 2004.

Goeree R, Farahati F, Burke N, Blackhouse G, O'Reilly D, Pyne J, Tarride JE. Goeree R, et al. Curr Med Res Opin. 2005 Dec;21(12):2017-28. doi: 10.1185/030079905X75087. Curr Med Res Opin. 2005. PMID: 16368053

9

The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all.

Pericleous L, Amin M, Goeree R. Pericleous L, et al. Among authors: goeree r. J Med Econ. 2019 May;22(5):478-487. doi: 10.1080/13696998.2019.1582535. Epub 2019 Mar 4. J Med Econ. 2019. PMID: 30757934 Free article.

10

Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.

Goeree R, Bowen JM, Blackhouse G, Lazzam C, Cohen E, Chiu M, Hopkins R, Tarride JE, Tu JV. Goeree R, et al. Int J Technol Assess Health Care. 2009 Apr;25(2):196-207. doi: 10.1017/S0266462309090254. Epub 2009 Mar 31. Int J Technol Assess Health Care. 2009. PMID: 19331710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters